Bronstein, Gewirtz & Grossman, LLC Investigates Columbia Laboratories, Inc. – Business Wire

January 23, 2012 Posted By: Leave a comment
CBRX), concerning whether the company and certain of its officers and directors have violated federal securities laws. “significantly reduces the risk of preterm birth and neonatal morbidity.” On January 20, 2012, Columbia Laboratories confirmed that ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*

CAPTCHA Image

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>